Artykuły w czasopismach na temat „Clinical High-Risk State for Psychosis (CHR-P)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Clinical High-Risk State for Psychosis (CHR-P)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Ruas Resende, M. B., F. Agostinho, R. Nogueira, D. Cotovio, F. A. Silva, and R. Lousada. "Ultra-High-Risk that do not transition to psychosis. What happens?" European Psychiatry 67, S1 (2024): S737. http://dx.doi.org/10.1192/j.eurpsy.2024.1533.
Pełny tekst źródłaRichter, Anja, Evangelos Vassos, Matthew J. Kempton, et al. "S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY." Schizophrenia Bulletin 46, Supplement_1 (2020): S104. http://dx.doi.org/10.1093/schbul/sbaa031.241.
Pełny tekst źródłaOmelchenko, M. "Premorbid of depressive youth at clinical high-risk for psychosis." European Psychiatry 65, S1 (2022): S683. http://dx.doi.org/10.1192/j.eurpsy.2022.1757.
Pełny tekst źródłaFusar-Poli, Paolo. "The Clinical High-Risk State for Psychosis (CHR-P), Version II." Schizophrenia Bulletin 43, no. 1 (2017): 44–47. http://dx.doi.org/10.1093/schbul/sbw158.
Pełny tekst źródłaCleusix, Martine, Ines Khadimallah, Elodie Toffel, et al. "S69. CLINICAL HIGH RISK STATE: STRATIFICATION BASED ON CLINICAL PROFILE AND REDOX STATUS." Schizophrenia Bulletin 46, Supplement_1 (2020): S60. http://dx.doi.org/10.1093/schbul/sbaa031.135.
Pełny tekst źródłaOmelchenko, M. A. "Clinical High Risk Psychosis: Issues of Diagnostics and Therapy." Psychiatry 18, no. 2 (2020): 82–91. http://dx.doi.org/10.30629/2618-6667-2020-18-2-82-91.
Pełny tekst źródłaDebbané, Martin, George Salaminios, Pablo Cascone, and Marco Armando. "Mentalizing the Clinical High-Risk for Psychosis Model: A Staged Intervention Framework." Psychodynamic Psychiatry 52, no. 4 (2024): 512–41. https://doi.org/10.1521/pdps.2024.52.4.512.
Pełny tekst źródłaLepock, Jennifer R., Romina Mizrahi, Michele Korostil, R. Michael Bagby, Elizabeth W. Pang, and Michael Kiang. "Event-Related Potentials in the Clinical High-Risk (CHR) State for Psychosis: A Systematic Review." Clinical EEG and Neuroscience 49, no. 4 (2018): 215–25. http://dx.doi.org/10.1177/1550059418755212.
Pełny tekst źródłaPoletti, Michele. "Early Intervention Services for youth at Clinical High-Risk for Psychosis: The Reggio Emilia At-Risk Mental State (ReARMS) experience." RIVISTA SPERIMENTALE DI FRENIATRIA 146, no. 3 (2022): 61–80. http://dx.doi.org/10.3280/rsf2022-003004.
Pełny tekst źródłaOliver, Dominic, Giulia Spada, Joaquim Radua, Philip McGuire, and Paolo Fusar-Poli. "M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES." Schizophrenia Bulletin 46, Supplement_1 (2020): S187. http://dx.doi.org/10.1093/schbul/sbaa030.448.
Pełny tekst źródłaKotlicka-Antczak, Magdalena, Michał S. Karbownik, Konrad Stawiski, et al. "Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state." European Psychiatry 58 (March 11, 2019): 72–79. http://dx.doi.org/10.1016/j.eurpsy.2019.02.007.
Pełny tekst źródłaSkuhareuskaya, M., and O. Skugarevsky. "Predictors of transition to psychosis in individuals at clinical high-risk for psychosis." European Psychiatry 41, S1 (2017): s838. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1651.
Pełny tekst źródłaZhen, Mao, Qijing Bo, Qing Tian, Fang Dong, Xianbin Li, and Chuanyue Wang. "T37. PREPULSE INHIBITION IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA AND CLINICAL-HIGH RISK WITHOUT FAMILY HISTORY OF PSYCHOSIS." Schizophrenia Bulletin 46, Supplement_1 (2020): S245—S246. http://dx.doi.org/10.1093/schbul/sbaa029.597.
Pełny tekst źródłaWei, Yanyan, Xiaochen Tang, Tingyu Zhang, et al. "Reduced temporal activation during a verbal fluency test in clinical high risk of psychosis: a functional near-infrared spectroscopy-based study." General Psychiatry 35, no. 2 (2022): e100702. http://dx.doi.org/10.1136/gpsych-2021-100702.
Pełny tekst źródłaKim, Ahra, Minji Ha, Taekwan Kim, et al. "Triple-Network Dysconnectivity in Patients With First-Episode Psychosis and Individuals at Clinical High Risk for Psychosis." Psychiatry Investigation 19, no. 12 (2022): 1037–45. http://dx.doi.org/10.30773/pi.2022.0091.
Pełny tekst źródłaSalazar de Pablo, Gonzalo, Scott W. Woods, Georgia Drymonitou, Héctor de Diego, and Paolo Fusar-Poli. "Prevalence of Individuals at Clinical High-Risk of Psychosis in the General Population and Clinical Samples: Systematic Review and Meta-Analysis." Brain Sciences 11, no. 11 (2021): 1544. http://dx.doi.org/10.3390/brainsci11111544.
Pełny tekst źródłaWadell, Paula. "62.2 Evidence-Based Treatment for Clinical High-Risk State for Psychosis (CHR-P) Syndromes." Journal of the American Academy of Child & Adolescent Psychiatry 61, no. 10 (2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.351.
Pełny tekst źródłaMenefee, Elizabeth. "62.1 Epidemiology and Diagnosis of Clinical High-Risk State for Psychosis (CHR-P) Syndromes." Journal of the American Academy of Child & Adolescent Psychiatry 61, no. 10 (2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.350.
Pełny tekst źródłaWorthington, Michelle, Jean Addington, Carrie Bearden, et al. "T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS." Schizophrenia Bulletin 46, Supplement_1 (2020): S274—S275. http://dx.doi.org/10.1093/schbul/sbaa029.676.
Pełny tekst źródłaGuo, Joyce Y., Tara A. Niendam, Andrea M. Auther, et al. "Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study." Psychological Medicine 50, no. 13 (2019): 2230–39. http://dx.doi.org/10.1017/s0033291719002332.
Pełny tekst źródłaHu, Yegang, Jun Wu, YuJiao Cao, et al. "Abnormal neural oscillations in clinical high risk for psychosis: a magnetoencephalography method study." General Psychiatry 35, no. 2 (2022): e100712. http://dx.doi.org/10.1136/gpsych-2021-100712.
Pełny tekst źródłaDe Micheli, Andrea, Albertine van Lawick van Pabst, Enass Yossef, Philip McGuire, and Paolo Fusar-Poli. "S154. TOBACCO SMOKING AND CLINICAL HIGH RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EVIDENCE." Schizophrenia Bulletin 46, Supplement_1 (2020): S94—S95. http://dx.doi.org/10.1093/schbul/sbaa031.220.
Pełny tekst źródłaAndreou, Christina, and Stefan Borgwardt. "Structural and functional imaging markers for susceptibility to psychosis." Molecular Psychiatry 25, no. 11 (2020): 2773–85. http://dx.doi.org/10.1038/s41380-020-0679-7.
Pełny tekst źródłaBreitborde, Nicholas J. K., Hossam Guirgis, Walter Stearns, et al. "The Ohio State University Early Psychosis Intervention Center (EPICENTER) step-based care programme for individuals at clinical high risk for psychosis: study protocol for an observational study." BMJ Open 10, no. 1 (2020): e034031. http://dx.doi.org/10.1136/bmjopen-2019-034031.
Pełny tekst źródłaCarrión, R. E., D. McLaughlin, A. M. Auther, R. Olsen, C. U. Correll, and B. A. Cornblatt. "The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis." Psychological Medicine 45, no. 15 (2015): 3341–54. http://dx.doi.org/10.1017/s0033291715001233.
Pełny tekst źródłaKhoury, Rita, and Henry A. Nasrallah. "Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?" Schizophrenia Research 199 (September 2018): 31–38. http://dx.doi.org/10.1016/j.schres.2018.04.017.
Pełny tekst źródłaModinos, Gemma, Anja Richter, Alice Egerton, et al. "Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes." Neuropsychopharmacology 46, no. 8 (2021): 1468–74. http://dx.doi.org/10.1038/s41386-021-01019-0.
Pełny tekst źródłaMillman, Zachary B., James M. Gold, Vijay A. Mittal, and Jason Schiffman. "The Critical Need for Help-Seeking Controls in Clinical High-Risk Research." Clinical Psychological Science 7, no. 6 (2019): 1171–89. http://dx.doi.org/10.1177/2167702619855660.
Pełny tekst źródłaFranscini, M., N. Traber-Walker, F. Probst, M. Gerstenberg, and S. Walitza. "Early detection and intervention of psychosis in children and adolescents in Zurich, Switzerland: Clinical Data from 2017-2022." European Psychiatry 66, S1 (2023): S1075—S1076. http://dx.doi.org/10.1192/j.eurpsy.2023.2284.
Pełny tekst źródłaCiarleglio, Adam J., Gary Brucato, Michael D. Masucci, et al. "A predictive model for conversion to psychosis in clinical high-risk patients." Psychological Medicine 49, no. 07 (2018): 1128–37. http://dx.doi.org/10.1017/s003329171800171x.
Pełny tekst źródłaPanikratova, Y., E. Abdullina, I. Lebedeva, M. Omelchenko, D. Tikhonov, and V. Kaleda. "Brain functional connectivity and local coherence in non-converters with clinical high risk for psychosis." European Psychiatry 66, S1 (2023): S612—S613. http://dx.doi.org/10.1192/j.eurpsy.2023.1277.
Pełny tekst źródłaBortoletto, Riccardo, Marco Garzitto, Fabiana Piscitelli, et al. "The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis." Brain Sciences 14, no. 12 (2024): 1230. https://doi.org/10.3390/brainsci14121230.
Pełny tekst źródłaHaining, Kate, Gina Brunner, Ruchika Gajwani, et al. "S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS." Schizophrenia Bulletin 46, Supplement_1 (2020): S57—S58. http://dx.doi.org/10.1093/schbul/sbaa031.130.
Pełny tekst źródłaFusar-Poli, Paolo, Matteo Rocchetti, Alberto Sardella, et al. "Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis." British Journal of Psychiatry 207, no. 3 (2015): 198–206. http://dx.doi.org/10.1192/bjp.bp.114.157115.
Pełny tekst źródłaIfrah, Chloe, Shaynna N. Herrera, Steven M. Silverstein, et al. "The Relationship between Clinical and Psychophysical Assessments of Visual Perceptual Disturbances in Individuals at Clinical High Risk for Psychosis: A Preliminary Study." Brain Sciences 14, no. 8 (2024): 819. http://dx.doi.org/10.3390/brainsci14080819.
Pełny tekst źródłaTomyshev, A. S., I. Lebedeva, A. Dudina, P. Menshchikov, D. Kupriyanov, and M. Omelchenko. "Reduced resting-state gamma-band power correlate with unaltered glutamate + glutamine levels in patients at clinical-high risk of psychosis." European Psychiatry 67, S1 (2024): S615. http://dx.doi.org/10.1192/j.eurpsy.2024.1280.
Pełny tekst źródłaCollin, Guusje, Alfonso Nieto-Castanon, Martha Shenton, et al. "S147. FUNCTIONAL BRAIN CONNECTIVITY DATA IMPROVE CLINICAL OUTCOME PREDICTION IN YOUTH AT RISK FOR PSYCHOSIS." Schizophrenia Bulletin 46, Supplement_1 (2020): S92. http://dx.doi.org/10.1093/schbul/sbaa031.213.
Pełny tekst źródłaMongan, David, Melanie Föcking, Colm Healy, et al. "T21. DEVELOPMENT OF PROTEOMIC PREDICTION MODELS FOR OUTCOMES IN THE CLINICAL HIGH RISK STATE AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE: MACHINE LEARNING ANALYSES IN TWO NESTED CASE-CONTROL STUDIES." Schizophrenia Bulletin 46, Supplement_1 (2020): S238—S239. http://dx.doi.org/10.1093/schbul/sbaa029.581.
Pełny tekst źródłaNeuner, L. M., L. Hahn, J. Kambeitz, et al. "Exploring Associations between Grey Matter Volume and Clinical High-Risk for Psychosis: A Transdiagnostic Study Utilizing the NAPLS-2 Risk Calculator in the PRONIA Cohort." European Psychiatry 67, S1 (2024): S271—S272. http://dx.doi.org/10.1192/j.eurpsy.2024.572.
Pełny tekst źródłaZajac, Jennifer. "62.3 An Innovative Intensive Outpatient Program for Adolescents With Clinical High-Risk State for Psychosis (CHR-P) Syndromes." Journal of the American Academy of Child & Adolescent Psychiatry 61, no. 10 (2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.352.
Pełny tekst źródłaDeVylder, J. E., S. Ben-David, S. A. Schobel, D. Kimhy, D. Malaspina, and C. M. Corcoran. "Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis." Psychological Medicine 43, no. 2 (2012): 259–68. http://dx.doi.org/10.1017/s0033291712001262.
Pełny tekst źródłaGraham-Sullivan, Patricia C. "62.4 Prevention and Therapy Approaches to Clinical High-Risk State for Psychosis (CHR-P) in an Intensive Outpatient Program." Journal of the American Academy of Child & Adolescent Psychiatry 61, no. 10 (2022): S84. http://dx.doi.org/10.1016/j.jaac.2022.07.353.
Pełny tekst źródłaOliver, D., M. Kotlicka-Antczak, A. Minichino, G. Spada, P. McGuire, and P. Fusar-Poli. "Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined prediction." European Psychiatry 49 (2018): 62–68. http://dx.doi.org/10.1016/j.eurpsy.2017.10.001.
Pełny tekst źródłaPopovic, D., C. Weyer, A. Ruef, et al. "Neuroinflammation in Recent Onset Mental Health Disorders – Developing Multi-level Signatures of Early-stage Depression and Psychosis in Young Adults." European Psychiatry 67, S1 (2024): S45—S47. http://dx.doi.org/10.1192/j.eurpsy.2024.147.
Pełny tekst źródłaAzis, Matilda, Gregory P. Strauss, Elaine Walker, William Revelle, Richard Zinbarg, and Vijay Mittal. "Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes." Schizophrenia Bulletin 45, no. 5 (2018): 1042–50. http://dx.doi.org/10.1093/schbul/sby177.
Pełny tekst źródłaHasmi, Laila, Lotta-Katrin Pries, Margreet ten Have, et al. "What makes the psychosis ‘clinical high risk’ state risky: psychosis itself or the co-presence of a non-psychotic disorder?" Epidemiology and Psychiatric Sciences 30 (2021). http://dx.doi.org/10.1017/s204579602100041x.
Pełny tekst źródłaHaining, Kate, Ruchika Gajwani, Joachim Gross, et al. "Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction." European Archives of Psychiatry and Clinical Neuroscience, August 16, 2021. http://dx.doi.org/10.1007/s00406-021-01315-2.
Pełny tekst źródłaOliver, Dominic, Maite Arribas, Joaquim Radua, et al. "Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis." Molecular Psychiatry, June 3, 2022. http://dx.doi.org/10.1038/s41380-022-01611-w.
Pełny tekst źródłaTikka, Sai Krishna, Barikar C. Malathesh, Mamidipalli Sai Spoorthy, et al. "Identification of youth at clinical high‐risk for psychosis: A community‐based study from India." Early Intervention in Psychiatry, May 28, 2024. http://dx.doi.org/10.1111/eip.13581.
Pełny tekst źródłaBaldwin, Helen, Joaquim Radua, Mathilde Antoniades, et al. "Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis." Translational Psychiatry 12, no. 1 (2022). http://dx.doi.org/10.1038/s41398-022-02057-y.
Pełny tekst źródła